Allschwil, CH – Idorsia Ltd. announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker and renal findings from the… Read More
KIRKLAND, QC – Merck , known as MSD outside the United States and Canada, announced that Health Canada has approved ENFLONSIA® (clesrovimab) for the prevention of respiratory syncytial virus (RSV) lower… Read More
KELOWNA, BC – Lexaria Bioscience Corp, a global innovator in drug delivery platforms is pleased to announce final results from Human Pilot Study #5 (GLP-1-H25-5) (the “Study”), which compared oral… Read More
UBC researchers used AI to identify sex differences in diabetic retinopathy that could be essential for precision diagnostics and care. Sex differences could play a key role in how vision… Read More
Expanded FDA approval across multiple cervical cancer screening modalities supports clinical flexibility and provider choice MARLBOROUGH, Mass – Hologic, Inc. announced that its Aptima® HPV Assay received FDA approval for… Read More
